Skip to content

A study on the effects of a new drug on the sensitivity of the nerves in healthy volunteers

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515390-99-00
Acronym
QRL-101-05
Enrollment
24
Registered
2024-09-05
Start date
2024-09-06
Completion date
2024-12-24
Last updated
2024-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperexcitability nerve disorder

Interventions

None listed

Sponsors

Quralis Corp.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026